Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1234-1242
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1234
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1234
Table 3 Patient characteristics according to hospital type and hospital volume in non-surgical treatment patients (n = 3955) n (%)
| Variables | Medical center | Hospital volume | Hospital volume | ||||||
| Yes | No | P value | Q1-2 | Q3-4 | P value | Q1-3 | Q4 | P value | |
| Sex | NS | NS | NS | ||||||
| Male | 2523 (95.0) | 1220 (94.0) | 1917 (94.2) | 1826 (95.1) | 2845 (94.8) | 898 (94.2) | |||
| Female | 133 (5.0) | 79 (6.0) | 118 (5.8) | 94 (4.9) | 157 (5.2) | 55 (5.8) | |||
| Age (yr) | < 0.05a | NS | NS | ||||||
| < 40 | 84 (3.2) | 29 (2.2) | 50 (2.5) | 63 (3.3) | 83 (2.8) | 30 (3.1) | |||
| 40-49 | 536 (20.2) | 315 (24.2) | 425 (20.1) | 426 (22.2) | 636 (21.2) | 215 (22.6) | |||
| 50-59 | 957 (36.0) | 433 (33.3) | 723 (35.5) | 667 (34.7) | 1052 (35.0) | 338 (35.5) | |||
| 60-69 | 587 (22.1) | 255 (19.6) | 417 (20.5) | 425 (22.1) | 645 (21.5) | 197 (20.7) | |||
| 70-79 | 304 (11.4) | 187 (14.4) | 270 (13.3) | 221 (11.5) | 371 (12.4) | 120 (12.6) | |||
| ≥ 80 | 188 (7.1) | 80 (6.2) | 150 (7.4) | 118 (6.1) | 215 (7.2) | 53 (5.6) | |||
| Tumor location | NS | < 0.01d | NS | ||||||
| Upper third | 759 (28.6) | 430 (33.1) | 680 (33.4) | 509 (26.5) | 642 (21.4) | 174 (18.3) | |||
| Middle third | 841 (31.7) | 501 (38.6) | 773 (38.0) | 569 (29.6) | 1079 (35.9) | 263 (27.6) | |||
| Lower third | 336 (12.7) | 169 (13.0) | 222 (10.9) | 283 (14.7) | 694 (23.1) | 184 (19.3) | |||
| Unknown | 720 (27.1) | 199 (15.3) | 360 (17.7) | 559 (29.1) | 587 (19.6) | 332 (34.8) | |||
| Tumor differentiation | NS | < 0.05c | < 0.01d | ||||||
| Well | 50 (1.9) | 27 (2.1) | 43 (2.1) | 34 (1.8) | 66 (2.2) | 11 (1.1) | |||
| Moderate | 985 (37.1) | 577 (44.4) | 910 (44.7) | 652 (34.0) | 1176 (39.1) | 386 (40.5) | |||
| Poorly | 547 (20.1) | 264 (20.3) | 428 (21.0) | 383 (19.9) | 534 (17.8) | 277 (29.1) | |||
| Unknown | 1074 (40.4) | 431 (33.2) | 654 (32.1) | 851 (44.3) | 1226 (40.8) | 279 (29.3) | |||
| Clinical stage | < 0.01b | < 0.01d | < 0.05c | ||||||
| 0/I | 70 (2.7) | 67 (5.2) | 77 (3.6) | 60 (3.3) | 111 (3.9) | 26 (2.5) | |||
| II | 272 (10.2) | 200 (15.4) | 298 (14.1) | 174 (9.5) | 375 (12.9) | 97 (9.3) | |||
| III | 1184 (44.6) | 509 (39.2) | 865 (40.9) | 828 (45.0) | 1233 (42.4) | 460 (43.9) | |||
| IV | 1071 (40.3) | 507 (39.0) | 841 (39.8) | 737 (40.0) | 1138 (39.1) | 440 (42.0) | |||
| Unknown | 59 (2.2) | 16 (1.2) | 32 (1.5) | 43 (2.3) | 51 (1.8) | 24 (2.3) | |||
| Treatment modality | < 0.05a | < 0.01d | < 0.01d | ||||||
| Chemotherapy | 234 (8.8) | 99 (7.6) | 175 (8.3) | 158 (8.6) | 228 (7.8) | 105 (10.0) | |||
| Radiotherapy | 259 (9.8) | 183 (14.1) | 282 (13.4) | 160 (8.7) | 362 (12.5) | 80 (7.6) | |||
| Chemoradiation | 2040 (76.8) | 980 (75.4) | 1572 (74.4) | 1448 (78.6) | 2206 (75.9) | 814 (77.8) | |||
| Unknown | 123 (4.6) | 37 (2.9) | 84 (4.0) | 76 (4.1) | 112 (3.9) | 48 (4.6) | |||
| Stage-specific 3-yr survival | |||||||||
| Stage I | 33.44% | 48.35% | 41.81% | 43.03% | 42.23% | 45.86% | |||
| Stage II | 21.1% | 21.12% | 22.53% | 18.74% | 22.60% | 15.76% | |||
| Stage III | 11.84% | 14.11% | 12.61% | 12.32% | 12.61% | 12.03% | |||
| Stage IV | 6.6% | 5.05% | 6.2% | 6.03% | 6.04% | 6.36% | |||
- Citation: Hsu PK, Chen HS, Wang BY, Wu SC, Liu CY, Shih CH, Liu CC. Hospital type- and volume-outcome relationships in esophageal cancer patients receiving non-surgical treatments. World J Gastroenterol 2015; 21(4): 1234-1242
- URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1234.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1234